Creating a conversation: Insights from the development of a decision aid

PLoS Medicine

Volumn 4, Issue 8, 2007, Pages 1303-1307

  Montori, Victor M ^a   Breslin, Maggie ^a   Maleska, Matthew ^a   Weymiller, Audrey J ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; LIPOPROTEIN BLOOD LEVEL; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; REVIEW; RISK REDUCTION; ARTICLE; ATTITUDE TO HEALTH; AUDIOVISUAL AID; DECISION SUPPORT SYSTEM; HEALTH PROMOTION; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT EDUCATION; PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AUDIOVISUAL AIDS; CARDIOVASCULAR DISEASES; DECISION SUPPORT TECHNIQUES; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PROGRAM DEVELOPMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 34548382712     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0040233     Document Type: Review

References (32)

1. Guyatt GH, Haynes B, Jaeschke R, Cook D, Greenhalgh T, et al. (2002) Introduction: The philosophy of evidence-based medicine. In: Guyatt GH, Rennie D, editors. Users' guides to the medical literature: A manual of evidence-based clinical practice. Chicago: American Medical Association. pp. 121-140.
2. Woolf SH, Chan EC, Harris R, Sheridan SL, Braddock CH 3rd, et al. (2005) Promoting informed choice: Transforming health care to dispense knowledge for decision making. Ann Intern Med 143: 293-300.
3. O'Connor AM, Stacey D, Entwistle V, Llewellyn-Thomas H, Rovner D, et al. (2003) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev: CD001431.
4. Roglic G, Unwin N, Bennett PH, Mathers C, Tuomilehto J, et al. (2005) The burden of mortality attributable to diabetes: Realistic estimates for the year 2000. Diabetes Care 28: 2130-2135.
5. Giesler PD, Bjornsen SS, Rahn DA, Smith SA, Montori VM (2004) Cardiovascular risk reduction and diabetes education: What are we telling our patients? Diabetes Educ 30: 994-999.
6. Gami AS, Montori VM, Erwin PJ, Khan MA, Smith SA (2003) Systematic review of lipid lowering for primary prevention of coronary heart disease in diabetes. BMJ 326: 528-529.
7. Vijan S, Hayward RA (2004) Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: Background paper for the American College of Physicians. Ann Intern Med 140: 650-658.
8. Snow V, Aronson MD, Hornbake ER, Mottur-Pilson C, Weiss KB (2004) Lipid control in the management of type 2 diabetes mellitus: A clinical practice guideline from the American College of Physicians. Ann Intern Med 140: 644-649.
9. Parris ES, Lawrence DB, Mohn LA, Long LB (2005) Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care 28: 595-599.
10. Jackevicius CA, Mamdani M, Tu JV (2002) Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 288: 462-467.
11. DiMatteo MR (2004) Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 42: 200-209.
12. Hearnshaw H, Lindenmeyer A (2006) What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med 23: 720-728.
13. Montori VM, Bryant SC, O'Connor AM, Jorgensen NW, Walsh EE, et al. (2003) Decisional attributes of patients with diabetes: The aspirin choice. Diabetes Care 26: 2804-2809.
14. Belcher VN, Fried TR, Agostini JV, Tinetti ME (2006) Views of older adults on patient participation in medication-related decision making. J Gen Intern Med 21: 298-303.
15. Hayward RA, Hofer TP, Vijan S (2006) Narrative review: Lack of evidence for recommended low-density lipoprotein treatment targets: A solvable problem. Ann Intern Med 145: 520-530.
16. Costa J, Borges M, David C, Vaz Carneiro A (2006) Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: Meta-analysis of randomised controlled trials. BMJ 332: 1115-1124.
17. Law M, Rudnicka AR (2006) Statin safety: A systematic review. Am J Cardiol 97: 52C-60C.
18. Graham DJ, Staffa JA, Shatin D, Andrade SE, Schech SD, et al. (2004) Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 292: 2585-2590.
19. McGettigan P, Sly K, O'Connell D, Hill S, Henry D (1999) The effects of information framing on the practices of physicians. J Gen Intern Med 14: 633-642.
20. Moxey A, O'Connell D, McGettigan P, Henry D (2003) Describing treatment effects to patients. J Gen Intern Med 18: 948-959.
21. Ancker JS, Senathirajah Y, Kukafka R, Starren JB (2006) Design features of graphs in health risk communication: A systematic review. J Am Med Inform Assoc 13: 608-618.
22. Epstein RM, Alper BS, Quill TE (2004) Communicating evidence for participatory decision making. JAMA 291: 2359-2366.
23. Trevena LJ, Davey HM, Barratt A, Butow P, Caldwell P (2006) A systematic review on communicating with patients about evidence. J Eval Clin Pract 12: 13-23.
24. Montori V, Leung T, Thompson C, Chung J, Capes S, et al. (2004) Choice of risk representation to enable diabetes decision-making. Diabetes 53 (Suppl 2): A225.
25. Holmes-Rovner M, Stableford S, Fagerlin A, Wei JT, Dunn RL, et al. (2005) Evidence-based patient choice: A prostate cancer decision aid in plain language. BMC Med Inform Decis Mak 5: 16.
26. Coughlan P, Suri JF, Canales K (2007) Prototypes as (design) tools for behavioral and organizational change: A design-based approach to help organizations change work behaviors. J Appl Behav Sci 43: 122-134.
27. Christianson TJ, Bryant SC, Weymiller AJ, Smith SA, Montori VM (2006) A pen-and-paper coronary risk estimator for office use with patients with type 2 diabetes. Mayo Clin Proc 81: 632-636.
28. Weymiller A, Montori V, Jones L, Gafni A, Guyatt G, et al. (2007) Helping patients with type 2 diabetes make treatment decisions: Statin choice randomized trial. Arch Intern Med: 167: 1076-1082.
29. Elwyn G, Hutchings H, Edwards A, Rapport F, Wensing M, et al. (2005) The OPTION scale: Measuring the extent that clinicians involve patients in decision-making tasks. Health Expect 8: 34-42.
30. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, et al. (2006) Developing a quality criteria framework for patient decision aids: Online international Delphi consensus process. BMJ 333: 417.
31. Feldman-Stewart D, Brundage MD, McConnell BA, MacKillop WJ (2000) Practical issues in assisting shared decision-making. Health Expect 3: 46-54.
32. Whelan T, Gafni A, Charles C, Levine M (2000) Lessons learned from the Decision Board: A unique and evolving decision aid. Health Expect 3: 69-76.